Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 643, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ijpharm.2023.123284
Keywords
Borneol; Graphene oxide; Brain-targeted delivery; Ginsenoside Rg1; Depression
Categories
Ask authors/readers for more resources
Depression is a chronic mental disorder that poses a threat to human health and well-being. The treatment of depression is challenging due to the blood brain barrier, which limits the distribution of antidepressant drugs in the brain. This study developed a brain-targeted drug delivery system using borneol-modified PEGylated graphene oxide, which showed promising potential for the treatment of depression by efficiently penetrating the blood brain barrier and exhibiting neuroprotective effects.
Depression is a chronic mental disorder which threatens human health and lives. However, the treatment of depression remains challenging largely due to blood brain barrier (BBB), which restricts drugs from entering the brain, resulting in a poor distribution of antidepressants in the brain. In this work, a novel brain-targeted drug delivery system was developed based on borneol-modified PEGylated graphene oxide (GO-PEG-BO). GO-PEG-BO was characterized and proved to possess excellent biocompatibility. By incorporating borneol, GO-PEG-BO could penetrate BBB efficiently by opening tight junctions and inhibiting the efflux system of BBB. The targeted distribution of GO-PEG-BO in the brain was observed by an in vivo biodistribution study. Moreover, GO-PEG-BO exhibited a neuroprotective effect, which is beneficial to the treatment of depression. Ginsenoside Rg1 (GRg1), which can relieve depressive symptoms but difficult to cross BBB, was loaded to GO-PEG-BO for the therapy of depression. In depressive rats, GRg1/GO-PEG-BO improved stress-induced anhedonia, despair and anxiety, and comprehensively relieved the depressive symptoms. In conclusion, GO-PEG-BO could serve as a promising nanocarrier for brain-targeted drug delivery, and provide a new strategy for the therapy of depression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available